LANE ANDREW H 4
4 · ABBOTT LABORATORIES · Filed May 7, 2020
Insider Transaction Report
Form 4
LANE ANDREW H
Senior Vice President
Transactions
- Exercise/Conversion
Common shares without par value
2020-05-05$38.40/sh+38,732$1,487,309→ 145,822 total - Sale
Common shares without par value
2020-05-05$92.00/sh−80,000$7,360,104→ 65,822 total - Exercise/Conversion
Option (right to buy)
2020-05-05−38,732→ 135,925 totalExercise: $38.40From: 2019-02-19Exp: 2026-02-18→ Common shares (38,732 underlying) - Exercise/Conversion
Common shares without par value
2020-05-05$48.90/sh+41,268$2,018,005→ 107,090 total - Exercise/Conversion
Option (right to buy)
2020-05-05−41,268→ 0 totalExercise: $48.90From: 2018-06-01Exp: 2025-05-31→ Common shares (41,268 underlying)
Holdings
- 1,428(indirect: By Trust)
Common shares without par value
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.00 to $92.02, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F2]Balance in the Abbott Laboratories Stock Retirement Trust as of May 5, 2020.
- [F3]Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.